<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Rev Bras Ter Intensiva</journal-id>
      <journal-id journal-id-type="iso-abbrev">Rev Bras Ter Intensiva</journal-id>
      <journal-title-group>
        <journal-title>Revista Brasileira de Terapia Intensiva</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0103-507X</issn>
      <issn pub-type="epub">1982-4335</issn>
      <publisher>
        <publisher-name>Associa&#xE7;&#xE3;o Brasileira de Medicina
intensiva</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25295829</article-id>
      <article-id pub-id-type="pmc">4188471</article-id>
      <article-id pub-id-type="doi">10.5935/0103-507X.20140046</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Fulminant myocarditis associated with the H1N1 influenza virus: case
report and literature review</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Miocardite fulminante associada ao v&#xED;rus influenza H1N1: relato
de caso e revis&#xE3;o de literatura</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lobo</surname>
            <given-names>Maria L&#xFA;cia Saraiva</given-names>
          </name>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Taguchi</surname>
            <given-names>&#xC2;ngela</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gaspar</surname>
            <given-names>Helo&#xED;sa Amaral</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ferranti</surname>
            <given-names>Juliana Ferreira</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Carvalho</surname>
            <given-names>Werther Brunow</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Delgado</surname>
            <given-names>Artur Figueiredo</given-names>
          </name>
        </contrib>
        <aff> Pediatric Intensive Care Unit, Instituto da Crian&#xE7;a, Hospital das
Cl&#xED;nicas, Faculdade de Medicina, Universidade de S&#xE3;o Paulo - S&#xE3;o
Paulo (SP), Brazil.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01"><bold>Corresponding author:</bold> Maria L&#xFA;cia Saraiva Lobo, Instituto da
Crian&#xE7;a do Hospital das Cl&#xED;nicas da Faculdade de Medicina da
Universidade de S&#xE3;o Paulo, Avenida Dr. En&#xE9;as de Carvalho Aguiar, 647 -
Cerqueira C&#xE9;sar, Zip code: 05403-000 - S&#xE3;o Paulo (SP), Brazil, E-mail:
<email>marluc@uol.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jul-Sep</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jul-Sep</season>
        <year>2014</year>
      </pub-date>
      <volume>26</volume>
      <issue>3</issue>
      <fpage>321</fpage>
      <lpage>326</lpage>
      <history>
        <date date-type="received">
          <day>01</day>
          <month>4</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>7</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>A case of fulminant myocarditis associated with the H1N1 influenza virus. This case
report describes the patient's clinical course and emphasizes the importance of
bedside echocardiography as an aid in the early diagnosis and management of children
with severe myocardial dysfunction. It also discusses aspects relevant to the
treatment and prognosis of fulminant myocarditis. The patient was a female, 4 years
and 8 months old, previously healthy and with a history of flu symptoms in the past
two weeks. The patient was admitted to the emergency room with signs of hemodynamic
instability, requiring ventilatory support and vasoactive drugs. The laboratory
tests, chest X-ray and echocardiogram suggested the presence of myocarditis. The test
for H1N1 in nasopharyngeal secretions was positive. The patient evolved to refractory
cardiogenic shock despite the clinical measures applied and died 48 hours after
admission to the intensive care unit. The H1N1 influenza virus is an etiological
agent associated with acute myocarditis, but there are few reported cases of
fulminant myocarditis caused by the H1N1 virus. The identification of signs and
symptoms suggestive of fulminant progression should be immediate, and bedside
echocardiography is a useful tool for the early detection of myocardial dysfunction
and for therapeutic guidance. The use of immunosuppressive therapy and antiviral
therapy in acute myocarditis of viral etiology is controversial; hence, the treatment
is based on hemodynamic and ventilatory support. The use of hemodynamic support by
extracorporeal membrane oxygenation emerges as a promising treatment.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Caso de miocardite fulminante associada ao v&#xED;rus influenza H1N1, em que foi
descrita a evolu&#xE7;&#xE3;o cl&#xED;nica do paciente e enfatizada a
import&#xE2;ncia do ecocardiograma &#xE0; beira do leito como aux&#xED;lio no
diagn&#xF3;stico precoce e manejo de crian&#xE7;as com disfun&#xE7;&#xE3;o
mioc&#xE1;rdica grave, al&#xE9;m de terem sido discutidos aspectos relevantes
relacionados &#xE0; terap&#xEA;utica e ao progn&#xF3;stico da miocardite
fulminante. Trata-se de paciente do sexo feminino, 4 anos e 8 meses, previamente
h&#xED;gida, com hist&#xF3;ria de quadro gripal h&#xE1; 2 semanas. Admitida no
pronto-socorro com sinais de instabilidade hemodin&#xE2;mica, necessitando de
suporte ventilat&#xF3;rio e drogas vasoativas. Exames laboratoriais, radiografia de
t&#xF3;rax e ecocardiograma sugestivos de miocardite. Pesquisa positiva para H1N1
em secre&#xE7;&#xE3;o de nasofaringe. Evoluiu com choque cardiog&#xEA;nico
refrat&#xE1;rio a despeito das medidas cl&#xED;nicas, indo a &#xF3;bito em 48
horas ap&#xF3;s admiss&#xE3;o na unidade de terapia intensiva. O v&#xED;rus
influenza H1N1 &#xE9; agente etiol&#xF3;gico associado a quadros de miocardite
aguda, por&#xE9;m poucos s&#xE3;o os casos relatados de miocardite fulminante
pelo v&#xED;rus H1N1. A identifica&#xE7;&#xE3;o de sinais e sintomas sugestivos
de evolu&#xE7;&#xE3;o fulminante deve ser imediata e o ecocardiograma &#xE0;
beira do leito &#xE9; uma ferramenta &#xFA;til para detec&#xE7;&#xE3;o
precoce de disfun&#xE7;&#xE3;o mioc&#xE1;rdica e orienta&#xE7;&#xE3;o
terap&#xEA;utica. O uso de terapia imunossupressora, em casos de miocardite
fulminante de etiologia viral, &#xE9; controverso, bem como o de terapia antiviral,
de tal forma que o tratamento baseia-se em suporte hemodin&#xE2;mico e
ventilat&#xF3;rio. O uso de suporte hemodin&#xE2;mico, por meio de
oxigena&#xE7;&#xE3;o por membrana extracorp&#xF3;rea, aparece como terapia
promissora.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Myocarditis</kwd>
        <kwd>Influenza, human</kwd>
        <kwd>Echocardiography</kwd>
        <kwd>Child</kwd>
        <kwd>Case reports</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Acute myocarditis exhibits a broad spectrum of clinical presentations. Fulminant acute
myocarditis presents with sudden onset of cardiac symptoms, which typically manifest
after nonspecific flu-like symptoms and rapidly progress to severe hemodynamic
deterioration with severe heart failure, cardiogenic shock and potentially fatal
arrhythmias. In pediatric patients, fulminant myocarditis corresponds to 30-40% of cases
of myocarditis and has a mortality rate of up to 48%, as reported in a recent
publication by Saji et al.<sup>(<xref rid="B01" ref-type="bibr">1</xref>)</sup> The
prevalence of myocardial involvement in infections by the influenza virus ranges from 0
to 11%, depending on the criteria used to define myocarditis.<sup>(<xref rid="B02" ref-type="bibr">2</xref>)</sup> Influenza A virus subtype H1N1, which is responsible for
the 2009 pandemic and which has since been the focus of attention of the World Health
Organization,<sup>(<xref rid="B03" ref-type="bibr">3</xref>)</sup> plays a role in
the pathogenesis of acute myocarditis.<sup>(<xref rid="B04" ref-type="bibr">4</xref>)</sup> However, there are few cases of fulminant myocarditis due to H1N1
influenza reported in the literature, especially in children.<sup>(<xref rid="B02" ref-type="bibr">2</xref>)</sup></p>
      <p>We report a case of fulminant myocarditis associated with the H1N1 influenza virus to
emphasize the importance of this virus as an etiological agent, describe the clinical
course, emphasize the importance of bedside echocardiography, and discuss aspects
relevant to the treatment and prognosis of fulminant myocarditis.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>Female patient, 4 years and 8 months old, previously healthy and with normal weight,
without prior vaccination for influenza virus. History of cough and rhinorrhea in the
last two weeks, with unmeasured fever. Two days prior, she presented with abdominal
pain, vomiting and poor general condition.</p>
      <p>She was admitted to the emergency room in poor general condition, severely dehydrated,
normotensive, moaning, tachypneic and tachycardic (<xref ref-type="table" rid="t01">Table 1</xref>). Initially diagnosed with septic shock, she received fluid
resuscitation with 70mL/kg crystalloid, oxygen therapy and empiric antibiotic therapy
(ceftriaxone 100mg/kg/day). Laboratory tests showed anemia, metabolic acidosis and
elevated C-reactive protein concentration (<xref ref-type="table" rid="t02">Table
2</xref>). Still in the emergency room, the patient evolved with worsening of the
tachydyspnea, hypotension and moaning, in addition to hepatomegaly, anasarca and
presence of heart murmur. Electrocardiogram showed sinus tachycardia (155 beats per
minute), and chest X-ray showed an enlarged cardiac area, mild right pleural effusion
and diffuse pulmonary infiltrates, suggesting alveolar congestion (<xref ref-type="fig" rid="f01">Figure 1</xref>). At that moment, a diagnosis of congestive heart failure
secondary to myocarditis or cardiomyopathy associated with sepsis was established.
Twelve hours after admission to the emergency room, due to hemodynamic deterioration and
signs of pulmonary congestion, diuretic and inotropic therapies (milrinone) were
initiated, with some improvement of the hemodynamic parameters (<xref ref-type="table" rid="t02">Table 2</xref>).</p>
      <table-wrap id="t01" orientation="portrait" position="float">
        <label>Table 1</label>
        <caption>
          <p>Test results throughout the clinical course</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="2" align="left" colspan="1">
<bold>Tests</bold>
</th>
              <th colspan="2" align="center" rowspan="1">
<bold>Emergency room</bold>
</th>
              <th align="center" rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1">&#xA0;</th>
              <th align="center" rowspan="1" colspan="1">
<bold>ICU</bold>
</th>
              <th align="center" rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <th rowspan="1" colspan="1">
<bold>6 hours</bold>
</th>
              <th rowspan="1" colspan="1">
<bold>18 hours</bold>
</th>
              <th rowspan="1" colspan="1">
<bold>0 hour</bold>
</th>
              <th rowspan="1" colspan="1">
<bold>12 hours</bold>
</th>
              <th rowspan="1" colspan="1">
<bold>18 hours</bold>
</th>
              <th rowspan="1" colspan="1">
<bold>24 hours</bold>
</th>
              <th rowspan="1" colspan="1">
<bold>36 hours</bold>
</th>
              <th rowspan="1" colspan="1">
<bold>40 hours</bold>
</th>
              <th rowspan="1" colspan="1">
<bold>48 hours</bold>
</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">Hemoglobin (g/dL)</td>
              <td align="center" rowspan="1" colspan="1">8.3</td>
              <td align="center" rowspan="1" colspan="1">7.7</td>
              <td align="center" rowspan="1" colspan="1">11</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">9.3</td>
              <td align="center" rowspan="1" colspan="1">9.6</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">9.4</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Hematocrit (%)</td>
              <td align="center" rowspan="1" colspan="1">25.9</td>
              <td align="center" rowspan="1" colspan="1">25</td>
              <td align="center" rowspan="1" colspan="1">34</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">29</td>
              <td align="center" rowspan="1" colspan="1">30</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">29</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Urea (mg/dL)</td>
              <td align="center" rowspan="1" colspan="1">33</td>
              <td align="center" rowspan="1" colspan="1">31</td>
              <td align="center" rowspan="1" colspan="1">32</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">44</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">39</td>
              <td align="center" rowspan="1" colspan="1">49</td>
              <td align="center" rowspan="1" colspan="1">58</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Creatinine (mg/dL)</td>
              <td align="center" rowspan="1" colspan="1">0.4</td>
              <td align="center" rowspan="1" colspan="1">0.33</td>
              <td align="center" rowspan="1" colspan="1">0.42</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">0.78</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">0.61</td>
              <td align="center" rowspan="1" colspan="1">0.99</td>
              <td align="center" rowspan="1" colspan="1">1.37</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Troponin (ng/dL)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">0.109</td>
              <td align="center" rowspan="1" colspan="1">0.151</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">0.259</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">CPK (U/L)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">162</td>
              <td align="center" rowspan="1" colspan="1">191</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">CK-MB (ng/mL)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">7.5</td>
              <td align="center" rowspan="1" colspan="1">8.8</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Myoglobin (ng/mL)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">2429</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">pH/Bic (mEq/L)</td>
              <td align="center" rowspan="1" colspan="1">7.36/19.2</td>
              <td align="center" rowspan="1" colspan="1">7.28/15.8</td>
              <td align="center" rowspan="1" colspan="1">7.36/17.7</td>
              <td align="center" rowspan="1" colspan="1">7.32/19.4</td>
              <td align="center" rowspan="1" colspan="1">7.37/19.8</td>
              <td align="center" rowspan="1" colspan="1">7.26/17.3</td>
              <td align="center" rowspan="1" colspan="1">7.18/17.0</td>
              <td align="center" rowspan="1" colspan="1">7.19/16.3</td>
              <td align="center" rowspan="1" colspan="1">7.25/17.2</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Lactate (mg/dL)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">14</td>
              <td align="center" rowspan="1" colspan="1">12</td>
              <td align="center" rowspan="1" colspan="1">11</td>
              <td align="center" rowspan="1" colspan="1">7</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">10</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">C-reactive protein (mg/L)</td>
              <td align="center" rowspan="1" colspan="1">158</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">90.88</td>
              <td align="center" rowspan="1" colspan="1">94.2</td>
              <td align="center" rowspan="1" colspan="1">84.29</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">103.83</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SvO<sub>2</sub> (%)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">83.3</td>
              <td align="center" rowspan="1" colspan="1">78</td>
              <td align="center" rowspan="1" colspan="1">52.4</td>
              <td align="center" rowspan="1" colspan="1">73.1</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn>
            <p>ICU - intensive care unit; CPK - creatinine phosphokinase; CK-MB - creatine
kinase MB isoenzyme; Bic - bicarbonate; SvO<sub>2</sub> - central venous oxygen
saturation. Reference values: CK-MB &lt;4.97ng/mL; CPK 26-192U/L; creatinine
0.31-0.47mg/dL; lactate 4.5-14mg/dL; myoglobin 25-58ng/dL; C-reactive protein
&lt;5mg/L; Troponin &lt;0.014ng/ml; urea 11-38g mg/dL.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="t02" orientation="portrait" position="float">
        <label>Table 2</label>
        <caption>
          <p>Vasoactive drugs and ventilatory and hemodynamic parameters</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="2" colspan="1">&#xA0;</th>
              <th colspan="2" align="center" rowspan="1">
<bold>Emergency room</bold>
</th>
              <th align="center" rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1"/>
              <th colspan="2" align="center" rowspan="1">
<bold>ICU</bold>
</th>
              <th align="center" rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <th align="center" rowspan="1" colspan="1">
<bold>6 hours</bold>
</th>
              <th align="center" rowspan="1" colspan="1">
<bold>18 hours</bold>
</th>
              <th align="center" rowspan="1" colspan="1">
<bold>0 hour</bold>
</th>
              <th align="center" rowspan="1" colspan="1">
<bold>6 hours</bold>
</th>
              <th align="center" rowspan="1" colspan="1">
<bold>12 hours</bold>
</th>
              <th align="center" rowspan="1" colspan="1">
<bold>18 hours</bold>
</th>
              <th align="center" rowspan="1" colspan="1">
<bold>24 hours</bold>
</th>
              <th align="center" rowspan="1" colspan="1">
<bold>36 hours</bold>
</th>
              <th align="center" rowspan="1" colspan="1">
<bold>42 hours</bold>
</th>
              <th align="center" rowspan="1" colspan="1">
<bold>48 hours</bold>
</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">Milrinone (mcg/kg/min)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">0.25</td>
              <td align="center" rowspan="1" colspan="1">0.25</td>
              <td align="center" rowspan="1" colspan="1">0.25</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">0.75</td>
              <td align="center" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Dobutamine (mcg/kg/min)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">10</td>
              <td align="center" rowspan="1" colspan="1">15</td>
              <td align="center" rowspan="1" colspan="1">15</td>
              <td align="center" rowspan="1" colspan="1">15</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Norepinephrine (mcg/kg/min)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">0.6</td>
              <td align="center" rowspan="1" colspan="1">1.2</td>
              <td align="center" rowspan="1" colspan="1">1.6</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Epinephrine (mcg/kg/min)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">0.3</td>
              <td align="center" rowspan="1" colspan="1">0.1</td>
              <td align="center" rowspan="1" colspan="1">0.1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Ventilatory support (cmH<sub>2</sub>O)</td>
              <td align="center" rowspan="1" colspan="1">Venturi</td>
              <td align="center" rowspan="1" colspan="1">Venturi</td>
              <td align="center" rowspan="1" colspan="1">NIV</td>
              <td align="center" rowspan="1" colspan="1">FiO<sub>2</sub> 100</td>
              <td align="center" rowspan="1" colspan="1">FiO<sub>2</sub> 55</td>
              <td align="center" rowspan="1" colspan="1">FiO<sub>2</sub> 55</td>
              <td align="center" rowspan="1" colspan="1">FiO<sub>2</sub> 55</td>
              <td align="center" rowspan="1" colspan="1">FiO<sub>2</sub> 100</td>
              <td align="center" rowspan="1" colspan="1">FiO<sub>2</sub> 100</td>
              <td align="center" rowspan="1" colspan="1">FiO<sub>2</sub> 100</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">50%</td>
              <td align="center" rowspan="1" colspan="1">50%</td>
              <td align="center" rowspan="1" colspan="1">FiO<sub>2</sub> 60%</td>
              <td align="center" rowspan="1" colspan="1">inspP34</td>
              <td align="center" rowspan="1" colspan="1">inspP27</td>
              <td align="center" rowspan="1" colspan="1">inspP27</td>
              <td align="center" rowspan="1" colspan="1">inspP27</td>
              <td align="center" rowspan="1" colspan="1">inspP30</td>
              <td align="center" rowspan="1" colspan="1">inspP32</td>
              <td align="center" rowspan="1" colspan="1">inspP32</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">IPAP16 EPAP8</td>
              <td align="center" rowspan="1" colspan="1">PEEP14 Fr26</td>
              <td align="center" rowspan="1" colspan="1">PEEP12 Fr22</td>
              <td align="center" rowspan="1" colspan="1">PEEP12 Fr22</td>
              <td align="center" rowspan="1" colspan="1">PEEP12 Fr22</td>
              <td align="center" rowspan="1" colspan="1">PEEP12 Fr22</td>
              <td align="center" rowspan="1" colspan="1">PEEP10 Fr25</td>
              <td align="center" rowspan="1" colspan="1">Peep10 F25</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SAP (mmHg)</td>
              <td align="center" rowspan="1" colspan="1">86x52</td>
              <td align="center" rowspan="1" colspan="1">100x50</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">85x46 (57)</td>
              <td align="center" rowspan="1" colspan="1">80x46 (61)</td>
              <td align="center" rowspan="1" colspan="1">78x41 (58)</td>
              <td align="center" rowspan="1" colspan="1">87x56 (67)</td>
              <td align="center" rowspan="1" colspan="1">74x41 (52)</td>
              <td align="center" rowspan="1" colspan="1">74x43 (59)</td>
              <td align="center" rowspan="1" colspan="1">61x41 (49)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">HR (bpm)</td>
              <td align="center" rowspan="1" colspan="1">166</td>
              <td align="center" rowspan="1" colspan="1">145</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">140</td>
              <td align="center" rowspan="1" colspan="1">155</td>
              <td align="center" rowspan="1" colspan="1">155</td>
              <td align="center" rowspan="1" colspan="1">145</td>
              <td align="center" rowspan="1" colspan="1">160</td>
              <td align="center" rowspan="1" colspan="1">173</td>
              <td align="center" rowspan="1" colspan="1">179</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Urine output (ml/kg/hour)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">3.5</td>
              <td align="center" rowspan="1" colspan="1">1.53</td>
              <td align="center" rowspan="1" colspan="1">0.7</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">0.44</td>
              <td align="center" rowspan="1" colspan="1">0.4</td>
              <td align="center" rowspan="1" colspan="1">0.2</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">CVP (mmHg)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">27</td>
              <td align="center" rowspan="1" colspan="1">22</td>
              <td align="center" rowspan="1" colspan="1">18</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">21</td>
              <td align="center" rowspan="1" colspan="1">21</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn>
            <p>ICU - intensive care unit; NIV - noninvasive ventilation; FiO<sub>2</sub> -
fraction of inspired oxygen (expressed in percentage); inspP - inspiratory
pressure (expressed in cmH<sub>2</sub>O); IPAP - Inspiratory pressure in NIV
(expressed in cmH<sub>2</sub>O); PEEP - end-expiratory pressure (expressed in
cm H<sub>2</sub>O); EPAP - Expiratory pressure in NIV (in cmH<sub>2</sub>O);
SAP - systemic arterial pressure; HR - heart rate; CVP - central venous
pressure.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <fig id="f01" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>(A) Chest X-ray after admission showing bilateral alveolar infiltrates. (B) Chest
X-ray after admission to the intensive care unit with worsening alveolar
infiltration and the presence of invasive devices (tracheal tube and central
venous catheter).</p>
        </caption>
        <graphic xlink:href="rbti-26-03-0321-g01"/>
      </fig>
      <p>Twenty-four hours after admission to the emergency room, the patient was transferred to
the intensive care unit (ICU), where she presented progressive worsening of respiratory
pattern, without improvement with noninvasive ventilation and requiring tracheal
intubation (six hours after ICU admission). A central venous catheter was inserted into
the right internal jugular vein (central venous pressure of 27mmHg), and the inotropic
and diuretic therapies were intensified without satisfactory clinical response (<xref ref-type="table" rid="t01">Table 1</xref>). An echocardiogram was performed by an ICU
physician and confirmed by the echocardiographer. The exam showed the following results:
ejection fraction of 27% (reference value - RV: &gt;60%), cardiac inde of
2.1L/min/m<sup>2</sup> (RV: 3.3 and 6.0L/min/m<sup>2</sup>) and left ventricular
diastolic diameter of 50mm (RV: &lt;20 mm), with the presence of diffuse left
ventricular hypokinesia and moderate insufficiency of the tricuspid and mitral valves
(<xref ref-type="fig" rid="f02">Figure 2</xref>). Dobutamine infusion, for the
treatment of severe cardiac dysfunction, and norepinephrine, due to the hypotension,
were added to the therapy. The antibiotic therapy was also broadened with the inclusion
of oxacillin and clarithromycin. Tests to identify the etiologic agent (search for
adenovirus, enterovirus serology, mycoplasma and identification of H1N1 in
nasopharyngeal secretions by polymerase chain reaction) were performed. Laboratory tests
showed elevated myocardial necrosis and inflammatory markers (<xref ref-type="table" rid="t01">Table 1</xref>). All cultures remained negative, and C-reactive protein
(CRP) was positive for H1N1. Despite clinical treatment, the patient did not show
improvement of her hemodynamic profile, staying in refractory shock. After the
introduction of adrenaline and an increase of the dose of the other vasoactive drugs,
the patient showed no clinical improvement. The patient died 48 hours after ICU
admission.</p>
      <fig id="f02" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>(A) Measurement of ejection fraction by M-mode; (B) measurement of cardiac index;
(C) apical 4-chamber image showing significant dilation of the left ventricle; (D)
presence of significant tricuspid insufficiency by color Doppler.</p>
          <p>LVDd - left ventricular end-diastolic diameter; LVDs - left ventricular
end-systolic diameter; VTI - velocity-time integral; RV - right ventricle; LV -
left ventricle; RA - right atrium; LA - left atrium; TI - tricuspid
insufficiency.</p>
        </caption>
        <graphic xlink:href="rbti-26-03-0321-g02"/>
      </fig>
      <p>Macroscopic histopathological analysis showed minor ascites, thickened mitral valve with
yellowish exudate deposition in valve leaflets and endocardium, signs of pulmonary
congestion and dilation of the left cardiac chambers (<xref ref-type="fig" rid="f03">Figure 3</xref>). Microscopically, the endocardium presented areas of necrosis
associated with the fibrin-leukocyte crust, and lymphocytic inflammatory infiltrate was
present in the myocardium with degeneration of some myocytes (<xref ref-type="fig" rid="f04">Figure 4</xref>). The pulmonary parenchyma exhibited signs of congestion,
with alveoli filled with hyaline membranous content (hyaline membrane) and extravasation
of red blood cells (<xref ref-type="fig" rid="f04">Figure 4</xref>). The hepatic
parenchyma was congested, with areas of ischemia in the central vein region.</p>
      <fig id="f03" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Macroscopy of the left ventricle. (A) Thickening of the mitral valve. (B)
Deposition of yellowish material in the endocardium.</p>
        </caption>
        <graphic xlink:href="rbti-26-03-0321-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>Figure 4</label>
        <caption>
          <p>(A) Lymphocytic inflammatory infiltrate in the myocardium with degeneration of
some myocytes; (B) interalveolar septum with signs of congestion; (C) alveoli
filled with hyaline membranous content.</p>
        </caption>
        <graphic xlink:href="rbti-26-03-0321-g04"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The clinical presentation of fulminant myocarditis of viral etiology is characterized by
the presence of nonspecific symptoms suggestive of viral infection, such as fever,
cough, runny nose, nausea, vomiting, abdominal pain and diarrhea, accompanied by
dyspnea, arrhythmia, syncope, heart failure and cardiogenic shock. Upon cardiac
examination, tachycardia, muffled first heart sound and third and fourth heart sound
gallop may be present. Patients with fulminant presentation, when compared to patients
with acute non-fulminant myocarditis, have higher heart rate, lower blood pressure and
higher elevation of myocardial necrosis markers and CRP, data that support the greater
severity and worse clinical outcome of these patients.<sup>(<xref rid="B01" ref-type="bibr">1</xref>)</sup> The diagnosis of fulminant viral myocarditis is based on
clinical and laboratory data, such as electrocardiogram, imaging tests
(echocardiography, myocardial scintigraphy and MRI) and endomyocardial biopsy for
histopathological analysis, as previously described.<sup>(<xref rid="B01" ref-type="bibr">1</xref>,<xref rid="B05" ref-type="bibr">5</xref>,<xref rid="B06" ref-type="bibr">6</xref>)</sup> The patient had a clinical history, physical
examination, laboratory tests (significant elevation of CRP and markers of myocardial
necrosis) and echocardiographic alterations consistent with fulminant myocarditis. The
clinical picture was preceded by flu-like symptoms, which directed the etiological
investigation to viral research, with subsequent confirmation of H1N1 influenza in the
nasopharyngeal secretions.</p>
      <p>Echocardiography is an important tool in the diagnosis of myocardial dysfunction and is
able to exclude other causes of heart failure, such as secondary to congenital heart
disease and valvular or pericardial diseases, and helps to identify the fulminant course
of the disease. Classical findings include global hypokinesia, with or without
pericardial effusion, variable degree of myocardial dilation and atrioventricular
regurgitation.<sup>(<xref rid="B07" ref-type="bibr">7</xref>)</sup> In this
report, the patient presented severe left ventricular systolic dysfunction, and the
initial echocardiographic evaluation was performed by a pediatric ICU physician, which
anticipated the detection of myocardial dysfunction and directed the early therapy to
fluid resuscitation and vasoactive drugs. Other studies in the literature also report
the advantages of medical emergency physicians being trained to perform echocardiograms,
specifically echocardiograms used for the evaluation of ventricular systolic function
and blood volume.<sup>(<xref rid="B08" ref-type="bibr">8</xref>)</sup></p>
      <p>Histological examination of the myocardium, although considered the gold standard by
certain experts, presents risks related to the procedure, which may make it prohibitive
in critically ill patients. Moreover, this procedure has limited utility due to sampling
errors, variations in interpretation, and undefined sensitivity for the detection of
viral genomes.<sup>(<xref rid="B09" ref-type="bibr">9</xref>)</sup> Immunohistochemical
analysis for specific markers, such as CD3 T lymphocytes, macrophages and leukocyte
antigens, may be further used for diagnosis together with coronary angiography and
MRI.<sup>(<xref rid="B06" ref-type="bibr">6</xref>,<xref rid="B09" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>)</sup> The patient did not
undergo endomyocardial biopsy, MRI or myocardial scintigraphy due to hemodynamic
instability. The post-mortem pathological examination showed deposition of yellowish
exudate in leaflets, associated with areas of necrosis in the endocardium with
inflammatory infiltrate and degeneration of myocytes, which reinforces the hypothesis of
cardiogenic shock due to fulminant myocarditis.</p>
      <p>Regarding the treatment of acute viral myocarditis in the pediatric population, there
are reports of a slight improvement in left ventricular function and increased survival
with the use of high-dose intravenous immunoglobulin, but there is no consensus in the
literature.<sup>(<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>)</sup> Immunosuppressive therapy was beneficial in the
subgroup of patients with giant cell acute myocarditis and myocarditis associated with
autoimmune disease, although no similar results were observed in patients with acute
viral myocarditis.<sup>(<xref rid="B13" ref-type="bibr">13</xref>)</sup> There is some
evidence that antiviral and antibacterial therapies show therapeutic benefit, but there
has been no randomized controlled study to determine the role of these drugs in the
course of myocarditis.<sup>(<xref rid="B13" ref-type="bibr">13</xref>)</sup> In the
reported case, the patient did not receive immunosuppressive, immunoglobulin or
antiviral therapy, and the treatment was based on intensive hemodynamic and ventilatory
support.</p>
      <p>Invasive mechanical ventilation is often required in cases of fulminant myocarditis with
cardiogenic shock. Oxygen-induced toxicity and high levels of positive end-expiratory
pressure should be avoided. Mild to moderate hyperventilation may help to correct
acidemia.<sup>(<xref rid="B14" ref-type="bibr">14</xref>)</sup> There are no
controlled studies that demonstrate better clinical outcomes with the use of a given
ventilation mode in this group of patients. It is known that methods that allow
spontaneous respiratory activity are associated with lower hemodynamic repercussions
because they tend to produce lower levels of mean airway pressure and pleural pressure.
However, patients with severe cardiogenic shock may benefit from controlled ventilatory
support, which is associated with reduced oxygen consumption. The choice of ventilatory
parameters depends on the experience of the ICU physician and the type of ventilation
equipment available in the unit; these parameters should be adjusted individually and
dynamically throughout the clinical course to ensure effective minute-volume
ventilation, optimize the work of breathing and minimize adverse hemodynamic
effects.<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup> The ventilatory
parameters used are shown in <xref ref-type="table" rid="t02">table 2</xref>.</p>
      <p>The hemodynamic support is based on the use of inotropic drugs, and the need for
vasopressor therapy in combination with inotropic therapy is common. Dobutamine is a
potent beta-1 agonist with a lower beta-2 and alpha agonist ability; it increases
myocardial contractility, reduces systemic vascular resistance and decreases the
pressure in the pulmonary capillaries, but it also has an arrhythmogenic effect.
Milrinone is a phosphodiesterase-3 inhibitor with inodilatory and lusitropic action.
This drug increases systolic volume and cardiac output, reduces the pressure in the
pulmonary vasculature and induces arrhythmia less frequently than dobutamine, but its
vasodilator effect limits its use in hypotensive patients, and the associated use of
vasopressor drugs may be necessary. The arterial vasoconstrictor norepinephrine is
useful in cases of hypotension; however, it increases cardiac oxygen consumption with no
increase in cardiac output. Epinephrine exerts a similar action to norepinephrine, but
with an inotropic effect, particularly when used in low doses. In cases of pulmonary
congestion, the use of intravenous diuretics should be considered.<sup>(<xref rid="B16" ref-type="bibr">16</xref>)</sup> In the reported case, the diagnosis of
myocardial dysfunction without hypotension guided the choice of milrinone as an initial
vasoactive drug. The lack of improvement in systolic left ventricular function (ejection
fraction of 27%) and development of hypotension led to the addition of dobutamine and
norepinephrine, respectively (<xref ref-type="table" rid="t02">Table 2</xref>).</p>
      <p>Despite intensive treatment, the mortality associated with fulminant myocarditis is
high. Ukimura et al. reported a mortality rate of 39% for patients with fulminant
myocarditis associated with the H1N1 influenza virus,<sup>(<xref rid="B17" ref-type="bibr">17</xref>)</sup> while Saji et al. reported a mortality rate of 83% in
patients with fulminant myocarditis who failed to respond to initial medical treatment
and who did not undergo mechanical circulatory support.<sup>(<xref rid="B01" ref-type="bibr">1</xref>)</sup> The use of extracorporeal membrane oxygenation in
patients with rapidly progressive heart failure and cardiogenic shock, unresponsive to
medical treatment, may reduce mortality from fulminant myocarditis to less than
20%.<sup>(<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B19" ref-type="bibr">19</xref>)</sup> The patient in this case report presented clinical
indication for the use of extracorporeal hemodynamic support, but we do not offer this
treatment in our service.</p>
      <p>Patients who survive acute fulminant myocarditis exhibit a favorable long-term
prognosis, with good recovery of cardiac function, which reinforces the importance of
adequate hemodynamic support in the acute phase of major cardiovascular
instability.<sup>(<xref rid="B20" ref-type="bibr">20</xref>)</sup></p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSION</title>
      <p>The H1N1 influenza virus should be considered an etiologic agent of myocarditis, and
features such as seasonality, endemic status and vaccination coverage should be
considered. In cases of fulminant progression, the identification of signs and symptoms
suggesting greater severity should be immediate, and bedside echocardiography may be
useful for the early detection of myocardial dysfunction and for therapeutic guidance.
The use of immunosuppressive or antiviral therapy for fulminant myocarditis of viral
etiology is controversial; hence, the treatment is based on hemodynamic and ventilatory
support. The use of extracorporeal membrane oxygenation therapy appears promising but
has not yet been routinely implemented in underdeveloped countries.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Conflict of interests:</bold> None.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Responsible editor:</bold> Jefferson Piva</p>
      </fn>
    </fn-group>
    <ack>
      <title>ACKNOWLEDGMENTS</title>
      <p>We thank the physicians Eduarda Damasceno Bittencourt and Arthur Ferreira Neto, both
from the Department of Pathology, for providing the images of the histopathological
examination.</p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saji</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsuura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nishikawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ohki</surname>
              <given-names>H</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Comparison of the clinical presentation, treatment, and outcome of
fulminant and acute myocarditis in children</article-title>
          <source>Circ J</source>
          <year>2012</year>
          <volume>76</volume>
          <issue>5</issue>
          <fpage>1222</fpage>
          <lpage>1228</lpage>
          <pub-id pub-id-type="pmid">22307381</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mamas</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Fraser</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Neyses</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Cardiovascular manifestations associated with influenza virus
infection</article-title>
          <source>Int J Cardiol</source>
          <year>2008</year>
          <volume>130</volume>
          <issue>3</issue>
          <fpage>304</fpage>
          <lpage>309</lpage>
          <pub-id pub-id-type="pmid">18625525</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fineberg</surname>
              <given-names>HV</given-names>
            </name>
          </person-group>
          <article-title>Pandemic preparedness and response-lessons from the H1N1 influenza of
2009</article-title>
          <source>N Engl J Med</source>
          <year>2014</year>
          <volume>370</volume>
          <issue>14</issue>
          <fpage>1335</fpage>
          <lpage>1342</lpage>
          <pub-id pub-id-type="pmid">24693893</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bratincs&#xE1;k</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>El-Said</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Bradley</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Shayan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Grossfeld</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Cannavino</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
          <article-title>Fulminant myocarditis associated with pandemic H1N1 influenza A virus
in children</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2010</year>
          <volume>55</volume>
          <issue>9</issue>
          <fpage>928</fpage>
          <lpage>929</lpage>
          <pub-id pub-id-type="pmid">20153131</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feldman</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>McNamara</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Myocarditis</article-title>
          <source>N Engl J Med</source>
          <year>2000</year>
          <volume>343</volume>
          <issue>19</issue>
          <fpage>1388</fpage>
          <lpage>1398</lpage>
          <pub-id pub-id-type="pmid">11070105</pub-id>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Alejos</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis and treatment of pediatric viral myocarditis</article-title>
          <source>Curr Opin Cardiol</source>
          <year>2001</year>
          <volume>16</volume>
          <issue>2</issue>
          <fpage>77</fpage>
          <lpage>83</lpage>
          <comment>Review</comment>
          <pub-id pub-id-type="pmid">11224637</pub-id>
        </element-citation>
      </ref>
      <ref id="B07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Felker</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Boehmer</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Hruban</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Hutchins</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Kasper</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Baughman</surname>
              <given-names>KL</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Echocardiographic findings in fulminant and acute
myocarditis</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2000</year>
          <volume>36</volume>
          <issue>1</issue>
          <fpage>227</fpage>
          <lpage>232</lpage>
          <pub-id pub-id-type="pmid">10898439</pub-id>
        </element-citation>
      </ref>
      <ref id="B08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Longjohn</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Joshi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Pershad</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Point-of-care echocardiography by pediatric emergency
physicians</article-title>
          <source>Pediatr Emerg Care</source>
          <year>2011</year>
          <volume>27</volume>
          <issue>8</issue>
          <fpage>693</fpage>
          <lpage>696</lpage>
          <pub-id pub-id-type="pmid">21811201</pub-id>
        </element-citation>
      </ref>
      <ref id="B09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baughman</surname>
              <given-names>KL</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis of myocarditis: death of Dallas criteria</article-title>
          <source>Circulation</source>
          <year>2006</year>
          <volume>113</volume>
          <issue>4</issue>
          <fpage>593</fpage>
          <lpage>595</lpage>
          <pub-id pub-id-type="pmid">16449736</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Friedrich</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Sechtem</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Schulz-Menger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Holmvang</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Alakija</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>LT</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Abdel-Aty</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gutberlet</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Prasad</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Aletras</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Laissy</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Paterson</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Filipchuk</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pauschinger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>P</given-names>
            </name>
            <collab>International Consensus Group on Cardiovascular Magnetic Resonance in
Myocarditis</collab>
          </person-group>
          <article-title>International Consensus Group on Cardiovascular magnetic resonance in
myocarditis: A JACC White Paper</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2009</year>
          <volume>53</volume>
          <issue>17</issue>
          <fpage>1475</fpage>
          <lpage>1487</lpage>
          <pub-id pub-id-type="pmid">19389557</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robinson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hartling</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Vandermeer</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Crumley</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Klassen</surname>
              <given-names>TP</given-names>
            </name>
          </person-group>
          <article-title>Intravenous immunoglobulin for presumed viral myocarditis in children
and adults</article-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2005</year>
          <issue>1</issue>
          <elocation-id/>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Camargo</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Snitcowsky</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>da Luz</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Mazzieri</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Higuchi</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Rati</surname>
              <given-names>M</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Favorable effects of immunosuppressive therapy in children with
dilated cardiomyopathy and active myocarditis</article-title>
          <source>Pediatr Cardiol</source>
          <year>1995</year>
          <volume>16</volume>
          <issue>2</issue>
          <fpage>61</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="pmid">7784236</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kindermann</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Barth</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mahfoud</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ukena</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lenski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yilmaz</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Update on myocarditis</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2012</year>
          <volume>59</volume>
          <issue>9</issue>
          <fpage>779</fpage>
          <lpage>792</lpage>
          <pub-id pub-id-type="pmid">22361396</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cooper</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Panza</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Cardiogenic shock</article-title>
          <source>Cardiol Clin</source>
          <year>2013</year>
          <volume>31</volume>
          <issue>4</issue>
          <fpage>567</fpage>
          <lpage>580</lpage>
          <page-range>567-80, viii</page-range>
          <comment>Review</comment>
          <pub-id pub-id-type="pmid">24188221</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corredor</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jaggar</surname>
              <given-names>SI</given-names>
            </name>
          </person-group>
          <article-title>Ventilator management in the cardiac intensive care
unit</article-title>
          <source>Cardiol Clin</source>
          <year>2013</year>
          <volume>31</volume>
          <issue>4</issue>
          <fpage>619</fpage>
          <lpage>636</lpage>
          <page-range>619-36, ix</page-range>
          <comment>Review</comment>
          <pub-id pub-id-type="pmid">24188225</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ginsberg</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Parrillo</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Fulminant myocarditis</article-title>
          <source>Crit Care Clin</source>
          <year>2013</year>
          <volume>29</volume>
          <issue>3</issue>
          <fpage>465</fpage>
          <lpage>483</lpage>
          <comment>Review</comment>
          <pub-id pub-id-type="pmid">23830649</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ukimura</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Izumi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsumori</surname>
              <given-names>A</given-names>
            </name>
            <collab>Clinical Research Committee on Myocarditis Associated with 2009 Influenza
A (H1N1) Pandemic in Japan organized by Japanese Circulation Society</collab>
          </person-group>
          <article-title>A national survey on myocarditis associated with the 2009 influenza A
(H1N1) pandemic in Japan</article-title>
          <source>Circ J</source>
          <year>2010</year>
          <volume>74</volume>
          <issue>10</issue>
          <fpage>2193</fpage>
          <lpage>2199</lpage>
          <pub-id pub-id-type="pmid">20697177</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duncan</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Bohn</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Atz</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>French</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Laussen</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Wessel</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Mechanical circulatory support for the treatment of children with
acute fulminant myocarditis</article-title>
          <source>J Thorac Cardiovasc Surg</source>
          <year>2001</year>
          <volume>122</volume>
          <issue>3</issue>
          <fpage>440</fpage>
          <lpage>448</lpage>
          <pub-id pub-id-type="pmid">11547292</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bohn</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Macrae</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>Acute viral myocarditis: mechanical circulatory
support</article-title>
          <source>Pediatr Crit Care Med</source>
          <year>2006</year>
          <volume>7</volume>
          <issue>6</issue>
          <fpage>S21</fpage>
          <lpage>S24</lpage>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schultz</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Hilliard</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>LT</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Rihal</surname>
              <given-names>CS</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis and treatment of viral myocarditis</article-title>
          <source>Mayo Clin Proc</source>
          <year>2009</year>
          <volume>84</volume>
          <issue>11</issue>
          <fpage>1001</fpage>
          <lpage>1009</lpage>
          <pub-id pub-id-type="pmid">19880690</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
